Trial
NCT02515669
Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Hoffmann-La Roche
Collaborators
—
Condition
Muscular Dystrophy (DMD)
Intervention
RO7239361
Why stopped
A pre-planned futility analysis indicated lack of efficacy in study NCT03039686 and led to discontinuation of both ongoing studies in DMD.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-11-04